Schrage William G, Dietz Niki M, Eisenach John H, Joyner Michael J
Dept. of Anesthesiology, Joseph 4-184W, Mayo Clinic, Rochester, MN 55905, USA.
J Appl Physiol (1985). 2005 Apr;98(4):1251-7. doi: 10.1152/japplphysiol.00966.2004. Epub 2004 Nov 24.
The relative contributions of endothelium-dependent dilators [nitric oxide (NO), prostaglandins (PGs), and endothelium-derived hyperpolarizing factor (EDHF)] in human limbs are poorly understood. We tested the hypothesis that relative contributions of NO and PGs differ between endothelial agonists acetylcholine (ACh; 1, 2, and 4 microg.dl(-1).min(-1)) and bradykinin (BK; 6.25, 25, and 50 ng.dl(-1).min(-1)). We measured forearm blood flow (FBF) using venous occlusion plethysmography in 50 healthy volunteers (27 +/- 1 yr) in response to brachial artery infusion of ACh or BK in the absence and presence of inhibitors of NO synthase [NOS; with NG-monomethyl-L-arginine (L-NMMA)] and cyclooxygenase (COX; with ketorolac). Furthermore, we tested the idea that the NOS + COX-independent dilation (in the presence of L-NMMA + ketorolac, presumably EDHF) could be inhibited by exogenous NO administration, as reported in animal studies. FBF increased approximately 10-fold in the ACh control; L-NMMA reduced baseline FBF and ACh dilation, whereas addition of ketorolac had no further effect. Ketorolac alone did not alter ACh dilation, but addition of L-NMMA reduced ACh dilation significantly. For BK infusion, FBF increased approximately 10-fold in the control condition; L-NMMA tended to reduce BK dilation (P < 0.1), and addition of ketorolac significantly reduced BK dilation. Similar to ACh, ketorolac alone did not alter BK dilation, but addition of L-NMMA reduced BK dilation. To test the idea that NO can inhibit the NOS + COX-independent portion of dilation, we infused a dose of sodium nitroprusside (NO-clamp technique) during ACh or BK that restored the reduction in baseline blood flow due to L-NMMA. Regardless of treatment order, the NO clamp restored baseline FBF but did not reduce the NOS + COX-independent dilation to ACh or BK. We conclude that the contribution of NO and PGs differs between ACh and BK, with ACh being more dependent on NO and BK being mostly dependent on a NOS + COX-independent mechanism (EDHF) in healthy young adults. The NOS + COX-independent dilation does not appear sensitive to feedback inhibition from NO in the human forearm.
内皮依赖性舒张因子[一氧化氮(NO)、前列腺素(PGs)和内皮源性超极化因子(EDHF)]在人体四肢中的相对作用尚不清楚。我们检验了以下假设:在给予内皮激动剂乙酰胆碱(ACh;1、2和4μg·dl⁻¹·min⁻¹)和缓激肽(BK;6.25、25和50 ng·dl⁻¹·min⁻¹)时,NO和PGs的相对作用存在差异。我们使用静脉阻断体积描记法,在50名健康志愿者(27±1岁)中测量了前臂血流量(FBF),这些志愿者在给予或不给予一氧化氮合酶(NOS)抑制剂[用NG-单甲基-L-精氨酸(L-NMMA)]和环氧化酶(COX)抑制剂[用酮咯酸]的情况下,接受肱动脉输注ACh或BK。此外,我们还检验了一个观点,即如动物研究报道的那样,外源性给予NO可抑制NOS+COX非依赖性舒张(在L-NMMA+酮咯酸存在的情况下,推测为EDHF)。在ACh对照组中,FBF增加了约10倍;L-NMMA降低了基线FBF和ACh介导的舒张,而添加酮咯酸没有进一步影响。单独使用酮咯酸不会改变ACh介导的舒张,但添加L-NMMA会显著降低ACh介导的舒张。对于BK输注,在对照条件下FBF增加了约10倍;L-NMMA倾向于降低BK介导的舒张(P<0.1),添加酮咯酸显著降低了BK介导的舒张。与ACh相似,单独使用酮咯酸不会改变BK介导的舒张,但添加L-NMMA会降低BK介导的舒张。为了检验NO能否抑制舒张的NOS+COX非依赖性部分这一观点,我们在给予ACh或BK期间输注了一定剂量的硝普钠(NO钳夹技术),该剂量可恢复因L-NMMA导致的基线血流量降低。无论治疗顺序如何,NO钳夹恢复了基线FBF,但并未降低对ACh或BK的NOS+COX非依赖性舒张。我们得出结论,在健康年轻成年人中,ACh和BK之间,NO和PGs的作用存在差异,ACh更依赖于NO,而BK主要依赖于一种NOS+COX非依赖性机制(EDHF)。在人体前臂中,NOS+COX非依赖性舒张似乎对来自NO的反馈抑制不敏感。